Anti-U11/U12 RNP antibodies, which target the U11/U12 RNP complex consisting of several proteins involved in alternative mRNA splicing, have been recently demonstrated to associate with the presence of both gastrointestinal manifestations and ILD [37–39]. This evidence concerns the gene RNPC3 and interstitial lung disease.